T1	Age 24 35	54-year-old
T2	Gender 36 42	female
T3	Activity 47 55	admitted
E1	Activity:T3 
T4	Disease_disorder 107 109	HF
E2	Disease_disorder:T4 
T5	Time 137 156	three years earlier
E3	Time:T5 
T6	Disease_disorder 162 170	acute MI
E4	Disease_disorder:T6 
T7	Diagnostic_procedure 184 204	coronary angiography
E5	Diagnostic_procedure:T7 
T8	Sign_symptom 212 221	occlusion
E6	Sign_symptom:T8 
T9	Anatomical_structure 229 250	right coronary artery
R1	MODIFY Arg1:T9 Arg2:E6	
T10	Severity 206 211	total
R2	MODIFY Arg1:T10 Arg2:E6	
T11	Sign_symptom 256 278	collateral circulation
E7	Sign_symptom:T11 
T12	Anatomical_structure 288 319	left descending coronary artery
R3	MODIFY Arg1:T12 Arg2:E7	
T13	Lab 583 622	Nterminal-pro-brain natriuretic peptide
E8	Lab:T13 
T14	Lab_value 635 646	10581 pg/mL
T15	Quantitative_concept 635 646	10581 pg/mL
T16	Qualitative_concept 565 573	elevated
R4	MODIFY Arg1:T16 Arg2:E8	
R5	MODIFY Arg1:T14 Arg2:E8	
T17	Disease_disorder 456 465	Class III
E9	Disease_disorder:T17 
T18	Subject 483 531	New York Heart Association (NYHA) classification
R6	MODIFY Arg1:T18 Arg2:E9	
T19	Time 403 424	when MI was diagnosed
E10	Time:T19 
T20	Sign_symptom 649 668	cardiac enlargement
E11	Sign_symptom:T20 
T21	Therapeutic_procedure 356 377	coronary intervention
E12	Therapeutic_procedure:T21 
A1	POLARITY E12 NEG
T22	Lab 687 726	left ventricular end-diastolic diameter
E13	Lab:T22 
T23	Lab_value 735 740	81 mm
R7	MODIFY Arg1:T23 Arg2:E13	
T24	Qualitative_concept 677 686	increased
R8	MODIFY Arg1:T24 Arg2:E13	
T25	Lab 747 781	left ventricular ejection fraction
E14	Lab:T25 
T26	Lab_value 789 792	25%
T27	Qualitative_concept 743 746	low
R9	MODIFY Arg1:T27 Arg2:E14	
R10	MODIFY Arg1:T26 Arg2:E14	
T28	Sign_symptom 799 807	akinesis
E15	Sign_symptom:T28 
T29	Anatomical_structure 815 823	inferior
T30	Anatomical_structure 825 837	inferoseptal
T31	Anatomical_structure 842 855	inferolateral
T32	Anatomical_structure 856 861	walls
R11	MODIFY Arg1:T31 Arg2:T32	
R12	MODIFY Arg1:T30 Arg2:T32	
R13	MODIFY Arg1:T29 Arg2:T32	
R14	MODIFY Arg1:T32 Arg2:E15	
T33	Sign_symptom 881 892	hypokinesis
E16	Sign_symptom:T33 
T34	Anatomical_structure 896 929	other walls of the left ventricle
T35	Location 874 880	global
T36	Severity 867 873	severe
R15	MODIFY Arg1:T34 Arg2:E16	
R16	MODIFY Arg1:T35 Arg2:T34	
R17	MODIFY Arg1:T36 Arg2:E16	
T37	Disease_disorder 996 1017	arterial hypertension
E17	Disease_disorder:T37 
T38	Disease_disorder 1019 1040	hypercholesterolaemia
E18	Disease_disorder:T38 
T39	Disease_disorder 1042 1064	ventricular arrhythmia
E19	Disease_disorder:T39 
T40	Disease_disorder 976 979	CAD
E20	Disease_disorder:T40 
T41	Medication 1066 1076	carvedilol
E21	Medication:T41 
T42	Medication 1078 1086	ramipril
E22	Medication:T42 
T43	Medication 1088 1102	spironolactone
E23	Medication:T43 
T44	Medication 1104 1114	furosemide
E24	Medication:T44 
T45	Medication 1116 1128	atorvastatin
E25	Medication:T45 
T46	Medication 1130 1143	trimetazidine
E26	Medication:T46 
T47	Medication 1145 1152	aspirin
E27	Medication:T47 
T48	Time 1155 1171	Two months later
E28	Time:T48 
T49	Disease_disorder 1240 1253	NYHA class II
E29	Disease_disorder:T49 
T50	Lab 1255 1264	NT-proBNP
E30	Lab:T50 
T51	Lab 1277 1282	LVEDD
E31	Lab:T51 
T52	Lab 1290 1294	LVEF
E32	Lab:T52 
T53	Lab_value 1265 1275	1869 pg/mL
T54	Lab_value 1283 1288	73 mm
T55	Lab_value 1295 1298	35%
T56	Activity 1184 1193	admission
E33	Activity:T56 
T57	Qualitative_concept 1230 1238	improved
R18	MODIFY Arg1:T53 Arg2:E30	
R19	MODIFY Arg1:T54 Arg2:E31	
R20	MODIFY Arg1:T55 Arg2:E32	
R21	MODIFY Arg1:T57 Arg2:E30	
R22	MODIFY Arg1:T57 Arg2:E31	
R23	MODIFY Arg1:T57 Arg2:E32	
T58	Anatomical_structure 1304 1335	inferior and inferolateral wall
T59	Sign_symptom 1336 1344	akinesis
E34	Sign_symptom:T59 
T60	Sign_symptom 1358 1369	hypokinesis
E35	Sign_symptom:T60 
T61	Anatomical_structure 1373 1384	other walls
T62	Severity 1349 1357	moderate
R24	MODIFY Arg1:T58 Arg2:E34	
R25	MODIFY Arg1:T62 Arg2:E35	
R26	MODIFY Arg1:T61 Arg2:E35	
T63	Diagnostic_procedure 1387 1420	Cardiovascular magnetic resonance
E36	Diagnostic_procedure:T63 
T64	Sign_symptom 1462 1489	late gadolinium enhancement
E37	Sign_symptom:T64 
T65	Anatomical_structure 1503 1526	inferoseptal (mid-wall)
T66	Anatomical_structure 1528 1554	inferior (sub-endocardial)
T67	Anatomical_structure 1559 1585	inferolateral (transmural)
T68	Anatomical_structure 1586 1591	walls
R27	MODIFY Arg1:T67 Arg2:T68	
R28	MODIFY Arg1:T66 Arg2:T68	
R29	MODIFY Arg1:T65 Arg2:T68	
R30	MODIFY Arg1:T68 Arg2:E37	
T69	Sign_symptom 1625 1634	infection
E38	Sign_symptom:T69 
A2	POLARITY E38 NEG
T70	Disease_disorder 1638 1643	fever
E39	Disease_disorder:T70 
A3	POLARITY E39 NEG
T71	Sign_symptom 1661 1674	LV dilatation
E40	Sign_symptom:T71 
T72	Sign_symptom 1704 1707	LGE
E41	Sign_symptom:T72 
T73	Anatomical_structure 1731 1743	inferoseptal
T74	Anatomical_structure 1748 1756	inferior
T75	Anatomical_structure 1757 1762	walls
R31	MODIFY Arg1:T74 Arg2:T75	
R32	MODIFY Arg1:T73 Arg2:T75	
R33	MODIFY Arg1:T75 Arg2:E41	
T76	Qualitative_concept 1792 1809	slightly elevated
T77	Lab 1827 1837	troponin I
E42	Lab:T77 
T78	Lab_value 1839 1850	0.014 ng/mL
R34	MODIFY Arg1:T78 Arg2:E42	
R35	MODIFY Arg1:T76 Arg2:E42	
T79	Duration 1775 1786	persistence
E43	Duration:T79 
T80	Diagnostic_procedure 1853 1869	Echocardiography
E44	Diagnostic_procedure:T80 
T81	Sign_symptom 1909 1932	coronary artery changes
E45	Sign_symptom:T81 
T82	Diagnostic_procedure 2069 2090	endomyocardial biopsy
E46	Diagnostic_procedure:T82 
T83	Sign_symptom 2374 2397	ultrastructural changes
E47	Sign_symptom:T83 
T84	Anatomical_structure 2435 2445	myofibrils
T85	Anatomical_structure 2447 2454	nucleus
T86	Anatomical_structure 2456 2469	mitochondrion
T87	Anatomical_structure 2471 2492	endoplasmic reticulum
T88	Anatomical_structure 2494 2518	intercellular connection
T89	Anatomical_structure 2520 2533	blood vessels
R36	MODIFY Arg1:T84 Arg2:E47	
R37	MODIFY Arg1:T85 Arg2:E47	
R38	MODIFY Arg1:T86 Arg2:E47	
R39	MODIFY Arg1:T87 Arg2:E47	
R40	MODIFY Arg1:T88 Arg2:E47	
R41	MODIFY Arg1:T89 Arg2:E47	
T90	Disease_disorder 2543 2548	virus
E48	Disease_disorder:T90 
A4	POLARITY E48 NEG
T91	Diagnostic_procedure 2330 2364	Electron microscopy of EMB samples
E49	Diagnostic_procedure:T91 
T92	Sign_symptom 2185 2197	myocytolysis
E50	Sign_symptom:T92 
T93	Sign_symptom 2213 2221	fibrosis
E51	Sign_symptom:T93 
T94	Anatomical_structure 2202 2212	myocardial
R42	MODIFY Arg1:T94 Arg2:E51	
T95	Lab 2265 2268	CD3
E52	Lab:T95 
A5	POLARITY E52 NEG
T96	Lab 2270 2273	CD4
E53	Lab:T96 
A6	POLARITY E53 NEG
T97	Lab 2275 2293	CD8-positive cells
E54	Lab:T97 
A7	POLARITY E54 NEG
T98	Lab 2295 2305	single LCA
E55	Lab:T98 
A8	POLARITY E55 NEG
T99	Lab 2307 2326	CD68-positive cells
E56	Lab:T99 
A9	POLARITY E56 NEG
T100	Disease_disorder 2564 2566	HF
E57	Disease_disorder:T100 
T101	Disease_disorder 2571 2574	CAD
E58	Disease_disorder:T101 
T102	Medication 2575 2584	treatment
E59	Medication:T102 
T103	Time 2678 2696	three months later
E60	Time:T103 
T104	Activity 2713 2727	rehospitalised
E61	Activity:T104 
T105	Disease_disorder 2739 2741	HF
E62	Disease_disorder:T105 
T106	Severity 2742 2754	exacerbation
R43	MODIFY Arg1:T106 Arg2:E62	
T107	Disease_disorder 2756 2770	NYHA Class III
E63	Disease_disorder:T107 
T108	Lab 2772 2781	NT-proBNP
E64	Lab:T108 
T109	Lab_value 2782 2792	1980 pg/dL
T110	Lab 2794 2802	troponin
E65	Lab:T110 
T111	Lab_value 2803 2810	3 ng/mL
T112	Lab 2812 2817	LVEDD
E66	Lab:T112 
T113	Lab_value 2818 2823	77 mm
T114	Lab 2825 2829	LVEF
E67	Lab:T114 
T115	Lab_value 2830 2833	30%
T116	Sign_symptom 2840 2865	ventricular extrasystoles
E68	Sign_symptom:T116 
T117	Quantitative_concept 2835 2839	8048
T118	Sign_symptom 2874 2887	complex forms
E69	Sign_symptom:T118 
A10	POLARITY E69 NEG
T119	Diagnostic_procedure 2891 2920	24-hour Holter ECG monitoring
E70	Diagnostic_procedure:T119 
R44	MODIFY Arg1:T109 Arg2:E64	
R45	MODIFY Arg1:T111 Arg2:E65	
R46	MODIFY Arg1:T113 Arg2:E66	
R47	MODIFY Arg1:T115 Arg2:E67	
R48	MODIFY Arg1:T117 Arg2:E68	
T120	Diagnostic_procedure 2938 2958	coronary angiography
E71	Diagnostic_procedure:T120 
T121	Diagnostic_procedure 3084 3131	real-time polymerase chain reaction examination
E72	Diagnostic_procedure:T121 
T122	Disease_disorder 3313 3333	viral cardiomyopathy
E73	Disease_disorder:T122 
T123	Sign_symptom 3300 3307	HEV RNA
E74	Sign_symptom:T123 
T124	Medication 3394 3406	interferon-β
E75	Medication:T124 
T125	Dosage 3457 3474	62.5 μg (0.25 mL)
T126	Detail_Description 3190 3231	samples collected during the previous EMB
R49	MODIFY Arg1:T126 Arg2:E72	
T127	Duration 3482 3492	first week
E76	Duration:T127 
T128	Dosage 3494 3509	125 μg (0.5 mL)
T129	Duration 3517 3539	second and third weeks
E77	Duration:T129 
T130	Dosage 3545 3563	187.5 μg (0.75 mL)
T131	Frequency 3579 3594	every other day
E78	Frequency:T131 
T132	Duration 3604 3636	fourth to the twenty-fourth week
E79	Duration:T132 
T133	Time 3640 3659	In the fourth month
E80	Time:T133 
T134	Diagnostic_procedure 3678 3681	EMB
E81	Diagnostic_procedure:T134 
T135	Sign_symptom 3703 3710	HEV RNA
E82	Sign_symptom:T135 
A11	POLARITY E82 NEG
T136	Time 3753 3769	After six months
E83	Time:T136 
T137	Qualitative_concept 3818 3826	improved
T138	Severity 3827 3840	significantly
R50	MODIFY Arg1:T138 Arg2:T137	
T139	Disease_disorder 3842 3854	NYHA class I
E84	Disease_disorder:T139 
T140	Lab 3856 3865	NT-proBNP
E85	Lab:T140 
T141	Lab_value 3866 3875	512 pg/mL
T142	Lab 3877 3882	LVEDD
E86	Lab:T142 
T143	Lab_value 3883 3888	68 mm
T144	Lab 3890 3894	LVEF
E87	Lab:T144 
T145	Lab_value 3895 3898	45%
T146	Qualitative_concept 3902 3910	decrease
T147	Sign_symptom 3928 3931	ExV
E88	Sign_symptom:T147 
T148	Diagnostic_procedure 3935 3949	24-hour Holter
E89	Diagnostic_procedure:T148 
T149	Quantitative_concept 3979 3983	1889
T150	Sign_symptom 3984 4010	ExV, without complex forms
E90	Sign_symptom:T150 
R51	MODIFY Arg1:T146 Arg2:E88	
R52	MODIFY Arg1:T149 Arg2:E90	
T151	Activity 4016 4038	adverse drug reactions
E91	Activity:T151 
A12	POLARITY E91 NEG
T152	Time 4053 4061	two-year
E92	Time:T152 
T153	Activity 4062 4071	follow-up
E93	Activity:T153 
T154	Other_entity 4076 4086	uneventful
R53	MODIFY Arg1:T154 Arg2:E93	
R55	MODIFY Arg1:T15 Arg2:E8	
T157	Quantitative_concept 735 740	81 mm
R57	MODIFY Arg1:T157 Arg2:E13	
T155	Quantitative_concept 789 791	25
R54	MODIFY Arg1:T155 Arg2:E14	
T156	Quantitative_concept 1265 1275	1869 pg/mL
R56	MODIFY Arg1:T156 Arg2:E30	
T158	Quantitative_concept 1283 1288	73 mm
R58	MODIFY Arg1:T158 Arg2:E31	
T159	Quantitative_concept 1295 1298	35%
R59	MODIFY Arg1:T159 Arg2:E32	
T160	Quantitative_concept 1839 1850	0.014 ng/mL
R60	MODIFY Arg1:T160 Arg2:E42	
T161	Quantitative_concept 2782 2792	1980 pg/dL
R61	MODIFY Arg1:T161 Arg2:E64	
T162	Quantitative_concept 2803 2810	3 ng/mL
R62	MODIFY Arg1:T162 Arg2:E65	
T163	Quantitative_concept 2818 2823	77 mm
R63	MODIFY Arg1:T163 Arg2:E66	
T164	Quantitative_concept 3866 3875	512 pg/mL
R64	MODIFY Arg1:T164 Arg2:E85	
T165	Quantitative_concept 3883 3888	68 mm
R65	MODIFY Arg1:T165 Arg2:E86	
T166	Quantitative_concept 3895 3898	45%
R66	MODIFY Arg1:T166 Arg2:E87	
